Literature DB >> 8042925

Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia.

W Samuel1, R D Terry, R DeTeresa, N Butters, E Masliah.   

Abstract

OBJECTIVE: We correlated severity of dementia in Alzheimer's disease with the degree of neuropathology in cortical and subcortical brain regions.
METHODS: In 13 patients with Alzheimer's disease who underwent neuropsychological testing before death, we assessed neurofibrillary tangles, senile plaques, and neuronal and synaptic density in the midfrontal cortex and the nucleus basalis of Meynert.
RESULTS: In the midfrontal cortex, synapse density was the strongest correlate of dementia severity, followed by neurofibrillary tangles. In the nucleus basalis, by contrast, neurofibrillary tangles were the strongest correlate, followed by synapse density. Stepwise regression analyses showed midfrontal synapse density to be the strongest predictor of tests emphasizing higher cortical functions, but neurofibrillary tangles in the nucleus basalis were the strongest predictor on memory-oriented tests.
CONCLUSIONS: The specificity of pathology in cortical vs subcortical locations for predicting a particular quality of neuropsychological deficit probably reflects disruption of corticocortical connections vs derangement of the basal forebrain cholinergic system.

Entities:  

Mesh:

Year:  1994        PMID: 8042925     DOI: 10.1001/archneur.1994.00540200048015

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  33 in total

1.  Age-related cerebral atrophy in nonhuman primates predicts cognitive impairments.

Authors:  Jean-Luc Picq; Fabienne Aujard; Andreas Volk; Marc Dhenain
Journal:  Neurobiol Aging       Date:  2010-10-22       Impact factor: 4.673

Review 2.  Vaccines for Alzheimer's disease: how close are we?

Authors:  Christopher Janus
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

3.  Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease.

Authors:  Cassia R Overk; Christian C Felder; Yuan Tu; Doug A Schober; Kelly R Bales; Joanne Wuu; Elliott J Mufson
Journal:  J Chem Neuroanat       Date:  2010-03-27       Impact factor: 3.052

4.  Enhanced dendritic spine number of neurons of the prefrontal cortex, hippocampus, and nucleus accumbens in old rats after chronic donepezil administration.

Authors:  Faviola Alcantara-Gonzalez; Ismael Juarez; Oscar Solis; Isaura Martinez-Tellez; Israel Camacho-Abrego; Eliezer Masliah; Raul Mena; Gonzalo Flores
Journal:  Synapse       Date:  2010-10       Impact factor: 2.562

Review 5.  The development of anti-amyloid therapy for Alzheimer's disease : from secretase modulators to polymerisation inhibitors.

Authors:  Paul S Aisen
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides.

Authors:  Gorazd B Stokin; Angels Almenar-Queralt; Shermali Gunawardena; Elizabeth M Rodrigues; Tomás Falzone; Jungsu Kim; Concepción Lillo; Stephanie L Mount; Elizabeth A Roberts; Eileen McGowan; David S Williams; Lawrence S B Goldstein
Journal:  Hum Mol Genet       Date:  2008-08-11       Impact factor: 6.150

7.  Hippocampal neuron loss is correlated with cognitive deficits in SAMP8 mice.

Authors:  Guomin Li; Haiyan Cheng; Xuezhu Zhang; Xuemei Shang; Hui Xie; Xin Zhang; Jianchun Yu; Jingxian Han
Journal:  Neurol Sci       Date:  2012-08-08       Impact factor: 3.307

Review 8.  Purkinje cell loss is a characteristic of essential tremor.

Authors:  Elan D Louis; Phyllis L Faust; John-Paul G Vonsattel
Journal:  Parkinsonism Relat Disord       Date:  2011-05-20       Impact factor: 4.891

9.  Adult neurogenesis is functionally associated with AD-like neurodegeneration.

Authors:  Qian Chen; Akira Nakajima; Se Hoon Choi; Xiaoli Xiong; Sangram S Sisodia; Ya-Ping Tang
Journal:  Neurobiol Dis       Date:  2007-11-05       Impact factor: 5.996

10.  A new tacrine-melatonin hybrid reduces amyloid burden and behavioral deficits in a mouse model of Alzheimer's disease.

Authors:  Carlos Spuch; Desiree Antequera; M Isabel Fernandez-Bachiller; M Isabel Rodríguez-Franco; Eva Carro
Journal:  Neurotox Res       Date:  2009-09-23       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.